Found 12 matching trials
A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia PHASE3 The purpose of the study is to evaluate the safety, tolerability and treatm...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities PHASE4 The purpose of this study is to evaluate the feasibility of conducting a st...
Show More Location
CARAES Ndera Neuro-Psychiatric Hospital
Learn More & Join Trial
A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia PHASE3 The purpose of this study is to compare the effectiveness and safety over 1...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings PHASE4 The purpose of this study is to assess the long-term symptomatic response (...
Show More Location
University Teaching Hospital of Butare(CHUB)
Learn More & Join Trial
A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia PHASE1 The purpose of this study is to assess the pharmacokinetics, safety, and to...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia. PHASE3 The purpose of this study is to evaluate the efficacy of paliperidone palmi...
Show More Location
Multiple Locations
Learn More & Join Trial
An Efficacy and Safety Study of Paliperidone Palmitate in Participants With Schizophrenia PHASE3 The purpose of this study is to evaluate the efficacy and safety of paliper...
Show More Location
Multiple Locations
Learn More & Join Trial
28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years PHASE4 The study will assess the use of paliperidone palmitate compared with oral ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia PHASE3 The purpose of this study is to demonstrate that a paliperidone palmitate 3...
Show More Location
Multiple Locations
Learn More & Join Trial
A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia PHASE4 The purpose of this study will be to evaluate the safety and treatment resp...
Show More Location
Multiple Locations
Learn More & Join Trial